📰 Stemcell Technologies News
Page 4 - Stemcell Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stemcell Technologies. Real-time updates on events, politics, business and more.
April 6, 2023
Human Primary Cell Market Business Strategies and Massive Demand by 2031
July 1, 2022
The remains of the young Irishman killed in a Vancouver hit-and-run are to arrive in Ireland on Saturday ahead of his funeral.
April 28, 2022
Scientists at BC Children’s Hospital are overjoyed about a potentially game-changing stem cell research technology that’s the first of its kind anywhere in the world.
March 22, 2022
VANCOUVER, BC, March 22, 2022 /PRNewswire/ -- The global cell expansion market is estimated to reach value of USD 39.74 Billion by 2027, according to a current analysis by Emergen Research.
May 26, 2021
Abstract The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has raised concern about potential immune escape. Here, we studied humoral and cellular immune responses to wild type SARS-CoV-2 and the B.1.1.7 and B.1.351 variants of concern in a cohort of 121 BNT162b2 mRNA-vaccinated health care workers (HCW). Twenty-three HCW recovered from mild COVID-19 disease and exhibited a recall response with high levels of SARS-CoV-2-specific functional antibodies and virus-sp...
May 8, 2021
B.C.âs âworld-classâ biotech sector plays key role in developing COVID-19 treatments and vaccines B.C.s biotech is punching above its weight, with key vaccine developments and helping develop treatments to ease the suffering of those infected Author of the article: Gordon Hoekstra Publishing date: May 08, 2021  â¢Â 3 hours ago  â¢Â 12 minute read  â¢Â The COVID-19 mRNA vaccine from Pfizer-BioNTech used technology developed in B.C. by Acuit...
May 7, 2021
B.C.âs âworld-classâ biotech sector plays key role in developing COVID-19 treatments and vaccines B.C.s biotech is punching above its weight, with key vaccine developments and helping develop treatments to ease the suffering of those infected Author of the article: Gordon Hoekstra Publishing date: May 07, 2021  â¢Â May 12, 2021  â¢Â 12 minute read  â¢Â The COVID-19 mRNA vaccine from Pfizer-BioNTech used technology developed in B.C. by Acuitas...
May 5, 2021
Global Primary Cells Market Size Worth US$ 1.7 Bn By 2025, Growing At A CAGR Of 10.8% iCrowd Newswire 06 May 2021, 05:47 GMT+10 Primary cells are booming on account of the escalating demand for monoclonal antibodies and the growing focus on personalized medicine. Primary cells are separated from human or animal tissue via enzymatic or mechanical methods. This cell is placed in an artificial environment in glass or plastic containers for support with a specialized medium containing essential nut...
May 5, 2021
Rising Demand For Tissue Engineering And Organ Transplantation Will Boost The Organoids And Spheroids Market, Forecast To Touch US$ 1.8 Bn By 2027 At A CAGR Of 19.8% iCrowd Newswire The organoids and spheroids market are growing at a steady pace on account of the innovation in the tissue culture system and frequent failures in organ transplantation surgeries, and the technological developments in the 3D spheroid technology. The growth of the organoids and spheroids market is further driven by ...
April 30, 2021
Abstract Duchenne muscular dystrophy (DMD) is a fatal muscle disease caused by the lack of dystrophin, which maintains muscle membrane integrity. We used an adenine base editor (ABE) to modify splice donor sites of the dystrophin gene, causing skipping of a common DMD deletion mutation of exon 51 (∆Ex51) in cardiomyocytes derived from human induced pluripotent stem cells, restoring dystrophin expression. Prime editing was also capable of reframing the dystrophin open reading frame in these ca...